These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30025788)

  • 1. Mathematical assessment of the role of Dengvaxia vaccine on the transmission dynamics of dengue serotypes.
    Iboi EA; Gumel AB
    Math Biosci; 2018 Oct; 304():25-47. PubMed ID: 30025788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission dynamics of two dengue serotypes with vaccination scenarios.
    González Morales NL; Núñez-López M; Ramos-Castañeda J; Velasco-Hernández JX
    Math Biosci; 2017 May; 287():54-71. PubMed ID: 27773682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Backward bifurcations in dengue transmission dynamics.
    Garba SM; Gumel AB; Abu Bakar MR
    Math Biosci; 2008 Sep; 215(1):11-25. PubMed ID: 18573507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of a two-sex model for the population ecology of dengue mosquitoes in the presence of Wolbachia.
    Taghikhani R; Sharomi O; Gumel AB
    Math Biosci; 2020 Oct; 328():108426. PubMed ID: 32712316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data.
    Maier SB; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Math Med Biol; 2021 Mar; 38(1):1-27. PubMed ID: 32671383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Optimal Age of Vaccination Against Dengue with an Age-Dependent Biting Rate with Application to Brazil.
    Maier SB; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Bull Math Biol; 2020 Jan; 82(1):12. PubMed ID: 31933012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Impact of Vaccination on the Dynamics of Dengue Infections.
    Knipl D; Moghadas SM
    Bull Math Biol; 2015 Dec; 77(12):2212-30. PubMed ID: 26585748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential opportunities and perils of imperfect dengue vaccines.
    Rodriguez-Barraquer I; Mier-y-Teran-Romero L; Schwartz IB; Burke DS; Cummings DA
    Vaccine; 2014 Jan; 32(4):514-20. PubMed ID: 24269318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing a dengue vaccination programme-who, where and how?
    E Clapham H; A Wills B
    Trans R Soc Trop Med Hyg; 2018 Aug; 112(8):367-368. PubMed ID: 30016491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal dengue vaccination strategies of seropositive individuals.
    Shim E
    Math Biosci Eng; 2019 Feb; 16(3):1171-1189. PubMed ID: 30947414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination.
    Coudeville L; Garnett GP
    PLoS One; 2012; 7(12):e51244. PubMed ID: 23251466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine.
    Maier SB; Huang X; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Math Biosci; 2017 Dec; 294():15-32. PubMed ID: 28935561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies.
    Coudeville L; Baurin N; Vergu E
    Vaccine; 2016 Dec; 34(50):6417-6425. PubMed ID: 26614588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults.
    Kirstein J; Douglas W; Thakur M; Boaz M; Papa T; Skipetrova A; Plennevaux E
    BMC Infect Dis; 2018 Sep; 18(1):475. PubMed ID: 30241510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Dengue Transmission Dynamic Model by Stability and Hopf Bifurcation with Two-Time Delays.
    Murugadoss PR; Ambalarajan V; Sivakumar V; Dhandapani PB; Baleanu D
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):117. PubMed ID: 37395028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the transmission dynamics of two-strain Dengue in the presence awareness and vector control.
    Zheng TT; Nie LF
    J Theor Biol; 2018 Apr; 443():82-91. PubMed ID: 29355543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort studies of dengue viral transmission and severity of disease.
    Endy TP; Yoon IK; Mammen MP
    Curr Top Microbiol Immunol; 2010; 338():1-13. PubMed ID: 19802574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.
    Tang B; Huo X; Xiao Y; Ruan S; Wu J
    Theor Biol Med Model; 2018 Sep; 15(1):13. PubMed ID: 30173664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.